Fund has been able to generate better returns compared to other funds in the same category
Less expense ratio implies better returns over the long term
Fund has been able to generate better price return than bank FD
Total holdings with red flags is insignificant
Expense RatioExpense Ratio | No LabelNo Label | No LabelNo Label |
---|---|---|
0.72 | 46.44 | 3.38 |
No LabelNo Label | No LabelNo Label | No LabelNo Label |
---|---|---|
1.47 | 54.30 | 3.32 |
PlanPlan | Lock inLock in | Exit LoadExit Load |
---|---|---|
IDCW | 0 yrs | 0.25% |
SIP Inv.SIP Inv. | Min. LumpsumMin. Lumpsum |
---|---|
Not allowed | Not allowed |
BenchmarkBenchmark |
---|
NIFTY PHARMA - TRI |
Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
Returns
Scheme
Ratios
Mutual Fund | 1Y Returns1Y Returns | 3Y CAGR3Y CAGR | Life CAGRLife CAGR |
---|---|---|---|
Tata India Pharma & Healthcare Fund(IDCW-Payout) | 58.51% | 22.38% | 15.69% |
Nippon India Pharma Fund(IDCW) | 43.06% | 16.65% | 12.38% |
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout) | 51.92% | 13.83% | 17.47% |
SBI Healthcare Opp Fund(IDCW-Payout) | 53.53% | 23.10% | 17.46% |
Actual
Target
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Equity
Others
Holdings
12.83 %
Holdings
8.96 %
Holdings
7.44 %
Established in 1994, Tata Asset Management Private Limited has a track record of more than 25 years in investment management. Tata Asset Management Private Limited manages investments of Tata Mutual Fund.
No.of Schemes
71
Total AUM
₹ 1,90,745.59 Cr.
Meeta Shetty
AUM: ₹23,941.11 Cr.
|
Exp: 12yrs
Rajat Srivastava
AUM: ₹1,183.18 Cr.
|
Exp: 8yrs
Manager Performance (0)
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%
Investment frequency
Monthly
One Time
Monthly Investment Amt. (₹)
Investment period (years)
You make
Outlook for the Pharma & Healthcare sector
3 years ago•Tata Mutual Fund
Tata India Pharma & Healthcare Fund Direct Growth Fund Review - Meeta Shetty | Mutual Fund Watch
4 years ago•Groww Mutual fund
8 Reasons to invest in Tata India Pharma & Healthcare Fund
4 years ago•Tata Mutual Fund
Meeta Shetty, Assistant Fund Manager's Views on Tata India Pharma & Healthcare Fund
4 years ago•Tata Mutual Fund
Returns
Fund has been able to generate better returns compared to other funds in the same category